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Abstract
Background: The guideline for postmastectomy radiotherapy (PMRT), which is prescribed to
reduce recurrence of breast cancer in the chest wall and improve overall survival, is not always
followed. Identifying and extracting important patterns of non-compliance are crucial in maintaining
the quality of care in Oncology.
Methods: Analysis of 759 patients with malignant breast cancer using decision tree induction (DTI)
found patterns of non-compliance with the guideline. The PMRT guideline was used to separate
cases according to the recommendation to receive or not receive PMRT. The two groups of
patients were analyzed separately. Resulting patterns were transformed into rules that were then
compared with the reasons that were extracted by manual inspection of records for the non-
compliant cases.
Results: Analyzing patients in the group who should receive PMRT according to the guideline did
not result in a robust decision tree. However, classification of the other group, patients who should
not receive PMRT treatment according to the guideline, resulted in a tree with nine leaves and
three of them were representing non-compliance with the guideline. In a comparison between
rules resulting from these three non-compliant patterns and manual inspection of patient records,
the following was found:
In the decision tree, presence of perigland growth is the most important variable followed by
number of malignantly invaded lymph nodes and level of Progesterone receptor. DNA index, age,
size of the tumor and level of Estrogen receptor are also involved but with less importance. From
manual inspection of the cases, the most frequent pattern for non-compliance is age above the
threshold followed by near cut-off values for risk factors and unknown reasons.
Conclusion: Comparison of patterns of non-compliance acquired from data mining and manual
inspection of patient records demonstrates that not all of the non-compliances are repetitive or
important. There are some overlaps between important variables acquired from manual inspection
of patient records and data mining but they are not identical. Data mining can highlight non-
compliance patterns valuable for guideline authors and for medical audit. Improving guidelines by
using feedback from data mining can improve the quality of care in oncology.
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Background
Recurrence of breast cancer is a major concern for patients
and health systems around the world. Most of them occur
in the first five years after initial treatment and can be in
the form of a local or a distant recurrence in the body [1].
Many patients with breast cancer are treated with breast
conserving surgery rather than mastectomy. However, a
considerable percentage of women still require or choose
the surgical procedure of mastectomy, which is complete
surgical removal of one or both breasts [2]. To reduce
recurrence of cancer in the chest wall and improve overall
survival, radiotherapy after mastectomy, or postmastec-
tomy radiotherapy (PMRT) of the chest wall and the
regional lymph nodes, is advised [3,4].
Clinical benefits related to PMRT depend on the treatment
technique and the risk of breast cancer recurrence. How-
ever, there is a trade-off between the benefits and the
adverse effects of this treatment. Therefore, a guideline
based on evidence obtained from different studies is used
for prescribing PMRT to patients who have undergone
mastectomy as their primary surgical treatment [5,6]. If
clinical guidelines are implemented successfully, the
results will generally be reduced costs and length of stay in
the hospital, minimized variations in medical practice,
and increased quality of care and patient satisfaction [7].
However, not all patients are treated according to guide-
lines. A number of reasons for this have been studied,
such as physicians' disagreement with guidelines [8].
Some of the barriers are associated with patient-related
obstacles [9]. In oncology, this can be due to patient char-
acteristics including tumor specifications such as size,
location and age. Patients may also have co-morbidities or
may not accept the suggested treatment.
Among different causes of inconsistencies between guide-
lines and the actual treatment, some reasons may be
retrieved from cancer quality registries. These registries
contain individual-based data on diagnoses, treatments
and outcomes and they play an important role in the con-
trol and improvement of health care quality [10].
A method for finding disagreements is to apply the PMRT
guideline to each case and compare the result with the
actual treatment received by the patient. Manual inspec-
tion is mainly done retrospectively by medical experts and
is time consuming. The deployment of automatic or semi-
automatic methods for systematic follow-up of compli-
ance based on the availability of proper data sources
would therefore be a great improvement in the field [11].
Clinical guidelines can be transformed into computer-
processable rules and integrated with interactive decision
support systems for providing feedback on decisions asso-
ciated with an individual patient [11]. However, a main
criterion is that necessary variables regarding the patient's
condition and treatment should be available in the data
source.
Data mining as a method for discovering meaningful new
patterns and trends [12] has in our case been used for
highlighting non-compliance with a guideline. With this
method, data can be analyzed in order to find repetitive
patterns and disagreements with a guideline. If proven
successful, instead of manually evaluating each case with
a guideline, a whole set of patients can be investigated
automatically. Several studies have used data mining
methods to find patterns in non-compliance with clinical
guidelines for diseases such as hypertension [13,14].
Variables of importance when prescribing PMRT, such as
age, tumor size and number of involved lymph nodes, are
present in the breast cancer registry. Therefore, analyzing
this registry using guideline rules can identify cases that
were not treated according to the guideline. It is also pos-
sible to partition patients according to the recommenda-
tions from guideline to patients who should or should not
receive the treatment. After identifying patterns for non-
compliance with the guideline, they should be verified via
manual inspection of patient medical records.
Decision tree models can visualize classification based on
a set of variables. The models can be used as a basis for dis-
cussions about reasons for non-compliance. Furthermore,
if some patterns are shown to be important in causing
non-compliance with the guideline, they should be fur-
ther investigated and reported to guideline authors.
The objective of this study was to identify patterns of non-
compliance with the PMRT guideline by studying a data-
set from a breast cancer registry. Patterns identified by
data mining were compared to reasons identified by man-
ual inspection of patient records.
Methods
By means of a locally adopted version of PMRT guideline
rules, cases were divided into two groups of patients,
those who should respectively should not receive PMRT
according to the guideline.
These two groups were analyzed with decision tree induc-
tion (DTI) to find noteworthy patterns of inappropriate
PMRT prescription. Medical records for each of the
patients that were not treated according to the guideline
were reviewed and the reasons for non-compliance were
extracted and categorized. Reasons acquired with these
two approaches, data mining and manual inspection,
were then compared.BMC Medical Informatics and Decision Making 2008, 8:41 http://www.biomedcentral.com/1472-6947/8/41
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Data Source and Variables
Data were collected from 759 female patients with the
diagnosis of malignant breast cancer and primary surgical
treatment with mastectomy. Patients were admitted to
Linköping University Hospital, and the earliest patient
was diagnosed on 1 January 1990 and the last one on 29
December 2000. During this period, the same PMRT
guideline was used for treating patients.
Variables from the tumor marker registry were linked and
matched with the main dataset. The tumor marker registry
contains information about tumor markers for breast can-
cer. After matching and retrieval of data, we could gather
data for twelve variables. These variables were age of the
patient at the time of diagnosis, number of involved
lymph nodes, tumor size, presence of multiple tumor,
location of the tumor, presence of perigland growth,
receptors for estrogen and progesterone, S-phase fraction,
DNA index, DNA ploidy and if the patient has received
PMRT treatment.
Thereafter, missing values for continuous variables in the
original dataset were handled using the expectation max-
imization (EM) method [15]. Three variables, namely per-
igland growth, presence of multiple tumor and location of
the tumor, were binary variables. Among these variables,
only presence of multiple tumor had 5% missing values
that were omitted from the study which resulted in 759
cases.
The analysis of patient records was approved by the
Linköping University ethics committee. No information
or clinical photographs relating to individual patient were
stated in this study.
The Guideline and Non-compliant Cases
In this study, adherence to the guideline for postmastec-
tomy radiotherapy was studied [6]. The original national
guideline was adopted at Linköping University Hospital
in order to conform to local experience [5]. A major mod-
ification was to suggest the treatment to patients with
involvement of one or more than one lymph node.
With knowledge of the actual treatment for each patient,
a table was constructed showing the recommendations
from the PMRT guideline and whether or not the patient
received this treatment. The cases that were not treated in
accordance with the guideline were identified and
extracted for further analysis. In order to process a com-
parison between the dataset and the guideline, the textual
guideline was manually converted to computer-processa-
ble format. Then these rules were applied to the dataset as
SQL queries to find cases that were not treated according
to the PMRT guideline.
In order to perform a comparison between the dataset and
the guideline, the textual guideline was manually con-
verted to computer-processable format. First, the variables
referred to in the guideline were identified and mapped to
the dataset, whereafter SQL queries were constructed cor-
responding to the logic of the guideline. Then these SQL
queries were applied to the database to identify cases that
were not treated according to the PMRT guideline. The
mapping procedure was performed by two of the authors
(ARR, NS) and checked by an experienced oncologist.
Because of the limited size of the PMRT guideline, the
whole process could be done manually. For more com-
plex and longer guidelines, guideline modelling method-
ologies such as GEM [16], PROforma [17] or GLIF [18]
should have been used.
As a quality control procedure, a biomedical analyst with
long experience in working with the breast cancer registry
used the ID numbers for these cases to find their medical
records. After reading the records, reasons for not follow-
ing the guideline were extracted, categorized and docu-
mented in a study protocol under the supervision of an
experienced oncologist. In some of the cases, such as
when the patient rejected the treatment, explicit reasons
for not following the guideline were documented in the
medical records. If the reason was not mentioned, such as
cases with near cut-off level values for risk factors, the bio-
medical analyst discussed the findings with the experi-
enced oncologist for pointing out reasons for non-
compliance.
Decision Tree Induction
Two groups of patients separated according to the PMRT
guideline were analyzed. One group consisted of patients
that according to the guideline should receive the treat-
ment (329 cases) and the other group included patients
who should not receive PMRT treatment (430 cases).
These groups were analyzed by data mining to group non-
compliant cases according to the set of variables. Decision
tree induction (DTI) was used to classify these cases. DTI
uses information gain as a heuristic for selecting the vari-
able that will best separate the cases into each outcome. In
a decision tree, each internal node denotes a test on a var-
iable, and each branch stands for an outcome of the test.
Leaf nodes represent an outcome, and the uppermost
node in a tree is the root node. The tree can be easily trans-
formed to rules and integrated into computer applica-
tions. The ability to create an understandable
representation of a classified dataset make decision trees
one of the most frequently used data mining techniques
[19]. For validating the result, 10-fold stratified cross vali-
dation was used. In this method, the data were randomly
divided into ten groups with equal proportions of PMRT.
Nine groups were used as the training set, and one was leftBMC Medical Informatics and Decision Making 2008, 8:41 http://www.biomedcentral.com/1472-6947/8/41
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for testing. This process was repeated ten times and at the
end the error rates were calculated as the average of ten
iterations of training and testing.
Results
125 cases (Table 1) were found to have been treated in
contrast to the PMRT guideline. Analysis of cases that
should receive PMRT according to the guideline did not
result in any decision tree that could discriminate between
compliant and non-compliant cases. On the other hand,
analyzing the other group consisting of patients who
should not receive PMRT treatment according to the
guideline resulted in a decision tree with the size of seven-
teen nodes and nine leaves. This decision tree is shown in
Figure 1. Three of the leaves show non-compliant cases,
i.e. cases that received PMRT treatment in contrast to the
guideline. In Table 2, pathways from the root node to
these three non-compliance leaves are shown as rules.
Regarding manual inspection, reasons for not following
PMRT guideline were extracted from the hospital informa-
tion system and the patient records and illustrated in
Table 3 and Table 4. Some of the cases had a combination
of reasons and all of them are presented in the tables.
Table 5 shows the comparison between reasons for pre-
scribing PMRT in contrast to the guideline and DTI.
Discussion
In order to identify noteworthy patterns of inappropriate
PMRT treatment, data mining was used to analyze groups
of patients already partitioned according to the guideline.
Comparison between the result from data mining and
manual inspection of non-compliant cases showed that
only in one of the groups, discrimination between com-
pliant/non-compliant cases is meaningful. A detailed dis-
cussion follows concerning comparison between results
from data mining and the manual inspection of cases.
Group One
This group consisted of patients who should not receive
PMRT treatment according to the guideline. Generally,
these patients do not benefit from PMRT because the dis-
ease is in earlier stages [6] or they are not good candidates
for PMRT for example due to comorbidities or being too
elderly. Manual inspection of cases in this group using the
guideline shows that the most common characteristic
among non-compliant cases was being older than 75
years, or having near cut-off level values for risk factors. In
some cases, the documentation in the patient record did
not reveal any specific reason for non-compliance (Table
5).
Age is directly related to the presence of comorbidities.
Older patients tend to have more comorbidities, and in
that case they are not good candidates for PMRT treat-
ment.
The most important variable identified by DTI was the
presence of perigland growth. This means that for discrim-
inating between compliant/non-compliant, this is the
most important variable. More variables characterizing
non-compliant cases identified by DTI are number of
lymph nodes that are invaded by malignant cells, Proges-
terone receptor level, DNA index, age, tumor size and
Estrogen receptor level. If variables are ranked according
to their importance, two variables from the guideline,
lymph node involvement status and age are placed in the
middle of the list. This can show that physicians consider
more risk factors for prescribing PMRT. Simply being
older than 75 years is apparently not a sufficient reason
for not to prescribe PMRT. It is however more common
for older patients to have other diseases and complica-
tions, which makes them less favourable candidates for
receiving PMRT.
This indicates that the above-mentioned variables may be
further investigated and reported to guideline authors for
consideration.
A better evaluation of non-compliance may be done by
applying fuzzy set theory (FST). If two patients who
received PMRT are 76 and 85 years old, both are older
than 75 years but the degree of non-compliance to the
guideline is different. Fuzzification of variable cut-offs can
give a more realistic estimation of non-compliance with
the guideline.
Group Two
This group consisted of patients who should receive PMRT
treatment according to the guideline. PMRT guideline is
based on evidence obtained from different studies and it
is shown that certain patients benefit from this treatment
in the form of reduced recurrence of the disease and also
improving survival of the patients [20,21]. Therefore,
non-compliance with the PMRT guideline can negatively
affect recurrence of the disease and survival of these
patients and repeated and important patterns should be
acted upon immediately.
Table 1: Contingency table for PMRT and decision according to 
the PMRT guideline.
Guideline PMRT
-+
Dataset PMRT - 356 51
+ 74 278BMC Medical Informatics and Decision Making 2008, 8:41 http://www.biomedcentral.com/1472-6947/8/41
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Analyzing this group of patients with data mining did not
result in a meaningful decision tree. Thus it was not pos-
sible to discriminate patients according to compliance
with the guideline. If there was a pattern for non-compli-
ance with the guideline, most probably DTI should have
identified it. Absence of such patterns indicate that there
is no repetitive or noteworthy pattern in not following
PMRT guideline for this group of patients, or that the can-
cer registry does not contain relevant variables for this
group. Reasons for refraining from PMRT are probably
more patient-related and unlikely to be present in the can-
cer registry.
Manual inspection of non-compliant cases in this group
(Table 4) reveals that the main reason for not prescribing
PMRT was the presence of co-morbidities (presence of one
or more diseases in addition to breast cancer) and a gen-
eralized disease. These two variables are not usually
reported in breast cancer registries. When physicians
deduce that the general condition of a patient is not good
and the disease is advanced, PMRT is not prescribed.
Cancer registries and non-compliances
Analyzing a regional breast cancer registry using PMRT
guideline rules reveals cases that are not treated according
to the guideline. This is a new way of using cancer regis-
tries, which are traditionally used for calculating survival
of cancer patients. In this case, the most important advan-
tage of using guideline rules is to save time in finding
these cases. In controlled studies, it is possible to manu-
ally inspect each patient's file. In routine clinical care, it is
not feasible to expect a medical expert to do this in order
to see whether a patient was treated according to one or a
set of guidelines. Therefore, any data source and method
that can contribute to systematic follow-up of guideline
compliance is beneficial. A combination of guideline
rules and DTI for analyzing data in a cancer registry is an
option.
There are reporting errors in 12 cases as shown in Table 3
and Table 4. Therefore, before using a breast cancer regis-
try for finding cases that were not treated according to the
PMRT guideline, a margin of registration error should be
considered. Discovering reporting errors may also
improve the data quality for further analyses and should
result in better quality control mechanisms. Rather low
quality of the dataset, i.e. due to reporting errors could
compromise the analysis results. In order to investigate
this, the dataset has been re-analysed without the report-
ing error cases. However, no important difference was
noticed between the results, showing the robustness of
data mining to find important patterns with respect to
reporting errors.
After identifying cases that were not treated according to
the guideline, the cases can be further investigated by
manual inspection of patient records. Furthermore, to
take advantage of new intelligent analytical methods, it is
beneficial to use data mining methods to extract a model
for viewing important non-compliance patterns. Discov-
ered reasons for non-compliance will of course be limited
to variables that are stored in the registries. It is also ben-
eficial to investigate patients belonging to these important
patterns separately, and in detail, by reviewing their
records. Missing values in PMRT is another factor that
affects identification of non-compliance patterns.
In some patients (17 cases), no obvious reason for non-
compliance with the guideline could be found. This is an
interesting finding, indicating that efforts should be made
to achieve a systematic and structured way of document-
ing clinical decision making in patient records.
Some studies have been conducted in which data mining
techniques were applied in order to find cases of non-
compliance with a specific guideline. Svatek et al. [14]
examined the automatic detection of potential explana-
Table 2: Left-hand side for the rules acquired from data mining in cases that are not recommended to receive PMRT but in contrast to 
the guideline have received PMRT.
No. 1 There are no perigland growth 
AND some lymph nodes are involved by malignant cells 
AND DNA index is more than 1 
AND patient is older than 79 years old 
AND Estrogen receptor level is less than or equal to 2 fmol/mg
No. 2 Perigland growth is present 
AND Progesterone level is more than 0.63 fmol/mg 
AND patient is younger than 81 years old
No. 3 Perigland growth is present 
AND Progesterone level is more than 0.63 fmol/mg 
AND patient is older than 81 years old 
AND tumor is larger than 24BMC Medical Informatics and Decision Making 2008, 8:41 http://www.biomedcentral.com/1472-6947/8/41
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tions of non-compliance by implementing association-
mining in the domain of hypertension management. They
proposed that frequent non-compliance patterns could be
submitted to medical experts for interpretation and they
examined their methodology with 48 patients. Our
approach, on the other hand, focused on comparisons
between patterns discovered by DTI from a regional can-
cer registry and reasons acquired by manual inspection of
patient records in the domain of oncology.
Marcos et al. [22] studied compliance with guidelines in
the domain of neonatal jaundice. Experts' solutions for a
set of cases were manually compared with those provided
by the formalized guideline. They identified some non-
Decision tree resulting from analyzing patients who should have not received PMRT treatment according to the guideline Figure 1
Decision tree resulting from analyzing patients who should have not received PMRT treatment according to 
the guideline. In the leaves (gray boxes), there are two numbers in parentheses. The first number shows the number of cases 
who reached this leaf and the second shows the number of cases for whom the leaf class was not predicted to happen. The 
number outside the parentheses indicates the class for cases that reach this leaf. 1 means non-compliant cases and 0 means 
compliant cases with PMRT guideline.
Perigland Growth
LN involvement
 = 0
PR
 = 1
0 (321.0/32.0)
<= 0
DNA Index
 > 0
0 (19.0)
<= 1
Age
 > 1
0 (7.0)
<= 79
ER
 > 79
1 (12.0/3.0)
<= 2
0 (20.0/4.0)
 > 2
0 (19.0/4.0)
 <= 0.63
Age
 > 0.63
1 (22.0/2.0)
<= 81
Tumor Size
 > 81
0 (5.0/1.0)
<= 24
1 (5.0/1.0)
 > 24BMC Medical Informatics and Decision Making 2008, 8:41 http://www.biomedcentral.com/1472-6947/8/41
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compliance patterns as local deviations, potential gaps in
the guidelines, and some artefacts of imperfect guideline
formalization. In our approach, physicians' decisions
were recorded as historical data in the registry and their
routine practices were studied. Asking their opinion about
individual patients may have added some bias, because
they would be prepared to give the best possible answer
about cases and to propose management that was similar
to the guideline. Our focus was to see if breast cancer reg-
istries could help to identify cases that were non-compli-
ant with the PMRT guideline and compare patterns
resulting from mining these historical data with reasons
acquired through manual inspection of patient records.
Future Work
Planning is underway to study the survival of patients and
to compare this between two groups, those who received
the right treatment according to the PMRT guideline and
those who did not. Testing the proposed methodology
with other data sources is another continuation of this
work.
Conclusion
Analyzing a regional breast cancer registry using guideline
rules for PMRT enables automatic detection of cases that
were not treated according to the guideline. Data mining
can reveal patterns of non-compliance with a guideline
provided that the variables referred to in the guideline are
recorded in the registry.
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Table 3: Reasons for prescribing PMRT, in contrast to the 
guideline.
Reasons Number
Physician-related 4
Patient-related Age above the threshold 40
Near cut-off level values for RFs 13
Advanced disease 4
Registry-related Reporting error 11
RT after local relapse 4
GL was followed 1
Unknown reason 4
RF: Risk factors, RT: Radiotherapy, GL: Guideline
Table 4: Reasons for not prescribing PMRT, in contrast to the 
guideline.
Reasons Number
Physician-related 5
Patient-related Co-morbidities 14
Rejected the treatment 3
Generalized disease 9
Early recurrence 5
Preoperative RT 3
Registry-related 1
GL was followed 1
Unknown reason 13
RT: Radiotherapy, GL: Guideline
Table 5: Results from data mining and manual inspection of records for cases who received PMRT treatment in contrast to the 
guideline.
Reasons Number
Rule 1 Rule 2 Rule 3
Patient-related Age above the threshold 82 04
Near cut-off level values for RFs -2-
Unknown reason 1--
RFs: Risk factorsPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Medical Informatics and Decision Making 2008, 8:41 http://www.biomedcentral.com/1472-6947/8/41
Page 8 of 8
(page number not for citation purposes)
Acknowledgements
With special thanks to Bo Nordenskjöld, Oncology professor, Birgitta Hol-
mlund, biomedical analyst at Oncology Centre, Linköping University Hos-
pital, and the South-East Swedish Breast Cancer Study Group for fruitful 
collaboration and support in this study. This study was supported by grant 
No. F2003-513 from FORSS, the Medical Research Council in the South-
East of Sweden.
References
1. Hiramanek N: Breast cancer recurrence: follow up after treat-
ment for primary breast cancer.  Postgrad Med J 2004,
80(941):172-6.
2. Martin MA, Meyricke R, O'Neill T, Roberts S: Breast-conserving
surgery versus mastectomy for survival from breast cancer:
the Western Australian experience.  Ann Surg Oncol 2007,
14(1):157-64.
3. Lee JC, Truong PT, Kader HA, Speers CH, Olivotto IA: Postmastec-
tomy radiotherapy reduces locoregional recurrence in eld-
erly women with high-risk breast cancer.  Clin Oncol (R Coll
Radiol) 2005, 17(8):623-9.
4. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F,
Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K: Post-
operative radiotherapy in high-risk premenopausal women
with breast cancer who receive adjuvant chemotherapy.
Danish Breast Cancer Cooperative Group 82b Trial.  N Engl J
Med 337(14):949-55. 1997 Oct 2
5. Nationella riktlinjer för behandling av bröstcancer, ver 1.1
och vårdprogram för sydöstra sjukvårdsregionen, ver 1.3.
[PDF] [cited 2007 28 November]  2006 [http://www.lio.se/us/
onkologisktcentrum].
6. Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, Flem-
ing GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR,
Langer AS, Sledge GW Jr, Whelan TJ, Pfister DG: Postmastectomy
radiotherapy: clinical practice guidelines of the American
Society of Clinical Oncology.  J Clin Oncol 19(5):1539-69. 2001
Mar 1;
7. Smith TJ, Hillner BE: Ensuring quality cancer care by the use of
clinical practice guidelines and critical pathways.  J Clin Oncol
19(11):2886-97. 2001 Jun 1;
8. Wall RJ, Dittus RS, Ely EW: Protocol-driven care in the intensive
care unit: a tool for quality.  Crit Care 2001, 5(6):283-5.
9. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA,
Rubin HR: Why don't physicians follow clinical practice guide-
lines? A framework for improvement.  JAMA 282(15):1458-65.
1999 Oct 20;
10. Garpenby P, Carlsson P: The role of national quality registers in
the Swedish health service.  Health Policy 1994, 29(3):183-95.
11. Peleg M, Keren S, Denekamp Y: Mapping computerized clinical
guidelines to electronic medical records: Knowledge-data
ontological mapper (KDOM).  J Biomed Inform . 2007 May 16.
12. Fayyad U, Stolorz P: Data mining and KDD: Promise and chal-
lenges.  Future Generation Computer Systems 1997, 13(2–3):99-115.
13. Persson M, Mjorndal T, Carlberg B, Bohlin J, Lindholm LH: Evalua-
tion of a computer-based decision support system for treat-
ment of hypertension with drugs: retrospective,
nonintervention testing of cost and guideline adherence.  J
Intern Med 2000, 247(1):87-93.
14. Svatek V, Riha A, Peleska J, Rauch J: Analysis of guideline compli-
ance–a data mining approach.  Stud Health Technol Inform 2004,
101:157-61.
15. McLachlan GJ, Krishnan T: The EM algorithm and extensions.
New York: John Wiley & Sons; 1997. 
16. Georg G, Seroussi B, Bouaud J: Extending the GEM model to
support knowledge extraction from textual guidelines.  Int J
Med Inform 2005, 74(2–4):79-87.
17. Sutton DR, Fox J: The syntax and semantics of the PROforma
guideline modeling language.  J Am Med Inform Assoc 2003,
10(5):433-43.
18. Boxwala AA, Peleg M, Tu S, Ogunyemi O, Zeng QT, Wang D, Patel
VL, Greenes RA, Shortliffe EH: GLIF3: a representation format
for sharable computer-interpretable clinical practice guide-
lines.  J Biomed Inform 2004, 37(3):147-61.
19. Han J, Kamber M: Data Mining Concepts and Techniques.  San
Francisco: Morgan Kaufmann; 2001. 
20. Dewar JA: Postmastectomy radiotherapy.  Clin Oncol (R Coll
Radiol) 2006, 18(3):185-90.
21. Yadav BS, Sharma SC, Singh R, Singh G, Kumar V: Postmastectomy
radiation and survival in patients with breast cancer.  J Cancer
Res Ther 2007, 3(4):218-24.
22. Marcos M, Balser M, ten Teije A, van Harmelen F: From informal
knowledge to formal logic: A realistic case study in medical
protocols.  Knowledge Engineering and Knowledge Management, Pro-
ceedings 2002, 2473:49-64.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6947/8/41/prepub